Filing Details
- Accession Number:
- 0001209191-23-007827
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-02-08 16:53:50
- Reporting Period:
- 2023-02-06
- Accepted Time:
- 2023-02-08 16:53:50
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1550395 | David Altshuler | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Evp, Global Research And Cso | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-02-06 | 1,304 | $187.53 | 69,949 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-02-06 | 12 | $300.39 | 69,937 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-02-06 | 70 | $302.00 | 69,867 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-02-06 | 100 | $303.64 | 69,767 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-02-06 | 349 | $305.08 | 69,418 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-02-06 | 620 | $306.70 | 68,798 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-02-06 | 153 | $309.06 | 68,645 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2023-02-06 | 1,304 | $0.00 | 1,304 | $187.53 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2029-02-05 | No | 4 | M | Direct |
Footnotes
- Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1.
- Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $303.64 (range $303.37 to $304.27).
- Open market sales reported on this line occurred at a weighted average price of $305.08 (range $304.72 to $305.43).
- Open market sales reported on this line occurred at a weighted average price of $306.70 (range $306.32 to $307.25).
- Open market sales reported on this line occurred at a weighted average price of $309.06 (range $308.76 to $309.42).
- Fully vested.
Billionaire Hedge Funds
